News
4h
Zacks.com on MSNIs Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...
1d
Verywell Health on MSNBMI Chart for Women of All Ages - MSNThe body mass index (BMI) chart helps determine obesity levels in both women and men. Healthcare providers also use it to ...
Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for market share, data f ...
Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock surged 10% after the company announced positive topline results from its Phase 2 trial evaluating bivamelagon, an investigational oral m ...
17h
Independent.ie on MSNAsk the doctor: My seven-year-old daughter is getting chubby – how do I stop it before it becomes an issue?Question: I have a seven-year-old daughter who is getting a little chubby. I give her fresh, healthy food in appropriate ...
6d
Zacks Investment Research on MSNHere's How Lilly's Non-Obesity Drugs are Contributing to Sales GrowthWhile Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...
Austin Public Health looks at 10 years worth of mortality data by disease, gender and race in new chronic disease report.
1d
News-Medical.Net on MSNNew study finds UK mums-to-be miss out on key nutrientsA new British Nutrition Foundation review finds that most UK women of reproductive age fall short of key nutrients before and ...
Nebraska Gov. Jim Pillen talks foreign trade, federal spending cuts and his once-rocky relationship with the president.
4d
ABP News on MSN8 Crucial Things To Know Before Bringing Home A LabradorPlanning to get a Labrador puppy? Discover 8 must-know facts about Labrador Retrievers before adopting. Learn about their ...
1d
News-Medical.Net on MSNTirzepatide tops the charts for blood sugar and weight loss in type 2 diabetesA large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
The rise of Ozempic and weight-loss drugs is a convenient excuse for the fashion industry and retailers to cut back on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results